---
schema_version: "secwatch.filing_event.v1"
accession: "0001730463-26-000043"
form_type: "8-K"
ticker: "AUTL"
cik: "0001730463"
company_name: "Autolus Therapeutics plc"
filed_at: "2026-04-08T23:59:59+00:00"
generated_at: "2026-05-15T06:54:07.427913+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Autolus hosts ALL Business investor event; presentation lacks specific financial data

## Summary
- Virtual investor event held on April 8, 2026, titled 'Spotlight on the Acute Lymphoblastic Leukemia (ALL) Business'.
- Presentation materials posted on company website and attached as Exhibit 99.1 to the 8-K filing.
- Filed under Regulation FD; only cover slide and disclaimer visible in the provided exhibit text.
- No new material financial, operational, or pipeline details are discernible from the filing content.
- Event appears to be a strategic update; no guidance or quantitative disclosures included.

## SEC filing metadata
- accession: 0001730463-26-000043
- form_type: 8-K
- ticker: AUTL
- cik: 0001730463
- company_name: Autolus Therapeutics plc
- filed_at: 2026-04-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1730463/000173046326000043/0001730463-26-000043-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1730463/000173046326000043/autl-20260408.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001730463-26-000043
- JSON: https://secwatch.observer/filing/0001730463-26-000043.json
- Plain text: https://secwatch.observer/filing/0001730463-26-000043.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.